Cyclosporine A and chlorambucil in the treatment of idiopathic focal segmental glomerulosclerosis Peter Heering, MD, Norbert Braun, MD, Reinhard Müllejans,

Slides:

Advertisements

Similar presentations

The Rise of Renal Pathology in Nephrology: Structure Illuminates Function Vivette D. D'Agati, MD, Michael Mengel, MD American Journal of Kidney Diseases.

Advertisements

Urinary Tract Infections in Patients With Urinary Diversion

Renal Function Testing

Diagnosis and Treatment of Hyponatremia

Peritoneal dialysis American Journal of Kidney Diseases

Gregory L. Hundemer, MD, MPH, Andrew Z. Fenves, MD, Kristy M

Phosphate Kinetic Models in Hemodialysis: A Systematic Review

Hypertension in the hemodialysis patient and the “lag phenomenon”: insights into pathophysiology and clinical management Uday M Khosla, MD, Richard J.

Citrate Plasma Levels in Patients Under Regional Anticoagulation in Continuous Venovenous Hemofiltration Gerd R. Hetzel, MD, Gediz Taskaya, Christoph.

Quiz Page March 2008 American Journal of Kidney Diseases

Dorian Schatell, MS, Meg Wise, PhD, Kristi Klicko, CHES, Bryan N

Association of Physical Activity and Renal Function in Subjects With and Without Metabolic Syndrome: A Review of the Third National Health and Nutrition.

American Journal of Kidney Diseases

American Journal of Kidney Diseases

Kostas C. Siamopoulos, MD, FRSH, Chariklia Gouva, MD, Konstantinos P

Amir Said Alizadeh Naderi, MD, Biff F. Palmer, MD

Impact of Comorbidities on Mortality in Managed Care Patients With CKD

Management of Acute Kidney Injury: Core Curriculum 2018

Urinary Tract Infections in Patients With Urinary Diversion

Dialysis Facility Ownership and Epoetin Dosing in Hemodialysis Patients: A Dialysis Provider’s Perspective J. Michael Lazarus, MD, Raymond M. Hakim,

Evaluation of the Potential Living Kidney Donor

Kidney Tattoos American Journal of Kidney Diseases

Hai-yan Wang, MD, American Journal of Kidney Diseases

Focusing on Health Literacy Might Help Us Cross the Quality Chasm

Wayne Trebbin, MD, Peter Monteleone, MD

Salt and Hypertension American Journal of Kidney Diseases

Karl D. Nolph, MD, American Journal of Kidney Diseases

Greg A. Knoll, MD, MSc American Journal of Kidney Diseases

Joseph A. Vassalotti, MD, Lesley A. Stevens, MD, MS, Andrew S

Anemia management for hemodialysis patients: Kidney Disease Outcomes Quality Initiative (K/DOQI) guidelines and Dialysis Outcomes and Practice Patterns.

Calcium-Alkali Syndrome Due to Vitamin D Administration and Magnesium Oxide Administration Shigeru Hanada, MD, Mari Iwamoto, MD, Namiko Kobayashi, MD,

Iva Gunnarsson, MD, PhD American Journal of Kidney Diseases

Hemoglobin Level and Transfusions in Patients on Maintenance Dialysis: Where the Rubber Meets the Road Eduardo Lacson, MD, MPH, Franklin Maddux, MD

Geriatrics American Journal of Kidney Diseases

On Statin Treatment to Prevent Sepsis in Dialysis Patients

Factors Influencing Route of Administration for Epoetin Treatment Among Hemodialysis Patients in the United States Mae Thamer, PhD, Yi Zhang, DDS, MS,

Hypertension in the hemodialysis patient and the “lag phenomenon”: insights into pathophysiology and clinical management Uday M Khosla, MD, Richard J.

Elevated Fibroblast Growth Factor 23 in a Patient With Metastatic Prostate Cancer and Hypophosphatemia Casey L. Cotant, MD, Panduranga S. Rao, MD, DNB,

A Decade After the KDOQI CKD Guidelines: A Perspective From Mexico

Salicylate Intoxication as a Cause of Pseudohyperchloremia

Prevalence and Severity of Renal Disease in Familial Dysautonomia

American Journal of Kidney Diseases

Quiz Page April 2008 American Journal of Kidney Diseases

Study Designs in Patient-Oriented Research

The Association of Lipid-Modifying Medications With Mortality in Patients on Long-Term Peritoneal Dialysis Alexander S. Goldfarb-Rumyantzev, MD, PhD,

Daniel E. Weiner, MD, MS, Mark J. Sarnak, MD, MS

Quiz Page August 2007 American Journal of Kidney Diseases

Risk for Incident Renal Dialysis in a Managed Care Population

Long-term Outcomes of Acute Kidney Injury: The Power and Pitfalls of Observational/Population-Based Studies Charuhas V. Thakar, MD American Journal.

Arnold S. Relman, MD, American Journal of Kidney Diseases

Removal of Dabigatran by Hemodialysis

Multidrug-Resistant Organisms Within the Dialysis Population: A Potentially Preventable Perfect Storm David P. Calfee, MD, MS American Journal of Kidney.

Making Music American Journal of Kidney Diseases

Kidney Failure Treatment: The Freedom to Choose

Achieving Fairness in Access to Kidney Transplant: A Work in Progress

MicroRNAs: A Macroview Into Focal Segmental Glomerulosclerosis

James F. Winchester, MD, Thomas H. Hostetter, MD, Timothy W. Meyer, MD

Supportive care for patients with renal disease: Time for action

Quiz Page June 2011 American Journal of Kidney Diseases

This Month in AJKD American Journal of Kidney Diseases

III. Treating dyslipidemias

Dialysis Research and N-of-1 Trials: Made for Each Other?

Quiz Page January 2010 American Journal of Kidney Diseases

Serum Leptin and Epoetin Sensitivity

Clinical Practice Recommendations For Peritoneal Dialysis Adequacy

IgA Nephropathy: A Disease in Search of a Large-Scale Clinical Trial to Reliably Inform Practice Giovanni F.M. Strippoli, MD, PhD, MPH (Hons), MM (Epi),

Peggy W. G. du Buf-Vereijken, MD, Amanda J. W. Branten, MD, Jack F. M

Clinical Practice Guidelines for Peritoneal Dialysis Adequacy

Quiz page December 2003 American Journal of Kidney Diseases

James A. Sloand, MD, Mark A. Shelly, MD

Presentation transcript:

Cyclosporine A and chlorambucil in the treatment of idiopathic focal segmental glomerulosclerosis Peter Heering, MD, Norbert Braun, MD, Reinhard Müllejans, MD, Katrin Ivens, MD, Ingeborg Zäuner, MD, Reinhard Fünfstück, MD, Frieder Keller, MD, Bernhard K Krämer, MD, Peter Schollmeyer, MD, Teut Risler, MD, Bernd Grabensee, MD American Journal of Kidney Diseases Volume 43, Issue 1, Pages 10-18 (January 2004) DOI: 10.1053/j.ajkd.2003.09.027 Copyright © 2004 National Kidney Foundation, Inc. Terms and Conditions

Fig 1 Follow-up of patients included in the study on the basis of an intention to treat. American Journal of Kidney Diseases 2004 43, 10-18DOI: (10.1053/j.ajkd.2003.09.027) Copyright © 2004 National Kidney Foundation, Inc. Terms and Conditions

Fig 2 Creatinine in the long-term monitoring of the 2 groups. There were 34 patients in group 1 and 23 in group 2 being analyzed to the end of the study. To convert creatinine in mg/dL to μmol/L, multiply by 88.4. American Journal of Kidney Diseases 2004 43, 10-18DOI: (10.1053/j.ajkd.2003.09.027) Copyright © 2004 National Kidney Foundation, Inc. Terms and Conditions

Fig 3 Renal survival in the long-term monitoring of the 2 groups. There were 34 patients in group 1 and 23 in group 2 being analyzed to the end of the study. American Journal of Kidney Diseases 2004 43, 10-18DOI: (10.1053/j.ajkd.2003.09.027) Copyright © 2004 National Kidney Foundation, Inc. Terms and Conditions

Fig 4 Cholesterol in the long-term monitoring of the 2 groups. There were 34 patients in group 1 and 23 in group 2 being analyzed to the end of the study. To convert cholesterol in mg/dL to mmol/L, multiply by 0.02586. American Journal of Kidney Diseases 2004 43, 10-18DOI: (10.1053/j.ajkd.2003.09.027) Copyright © 2004 National Kidney Foundation, Inc. Terms and Conditions

Fig 5 Proteinuria in the long-term monitoring of the 2 groups. There were 34 patients in group 1 and 23 in group 2 being analyzed to the end of the study. American Journal of Kidney Diseases 2004 43, 10-18DOI: (10.1053/j.ajkd.2003.09.027) Copyright © 2004 National Kidney Foundation, Inc. Terms and Conditions